Sphingolipids, mycobacteria and host: Unraveling the tug of war.

Mohammed, Shakeel Ahmed; Saini, Reena Vohra; Jha, Abhimanyu Kumar; Hadda, Vijay; Singh, Amit Kumar; Prakash, Hridayesh

Mohammed, Shakeel Ahmed; Saini, Reena Vohra; Jha, Abhimanyu Kumar; Hadda, Vijay; Singh, Amit Kumar; Prakash, Hridayesh.

Afiliação

Mohammed SA; Amity Institute of Virology and Immunology, Amity University, Noida, India.
Saini RV; Department of Biotechnology, Maharishi Markandeshwar (M. M). Engineering College, Maharishi Markandeshwar (Deemed to be University), Ambala, India.
Jha AK; Department of Biotechnology, Maharishi Markandeshwar (M. M). Engineering College, Maharishi Markandeshwar (Deemed to be University), Ambala, India.
Hadda V; Department of Biotechnology, Sharda University, Greater Noida, India.
Singh AK; Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences, New Delhi, India.
Prakash H; Experimental Animal Facility, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj Agra, India.

Front Immunol ; 13: 1003384, 2022.

Article em En | MEDLINE | ID: mdl-36189241

Assuntos

Infecções por Mycobacterium; Mycobacterium; Humanos; Esfingolipídeos

Palavras-chave

M1 effector macrophages; Sphingosine-1phosphate; iNOS; innate immunity significance; tuberculosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium / Infecções por Mycobacterium Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google